Equities

Stenocare A/S

Stenocare A/S

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (DKK)4.70
  • Today's Change-0.01 / -0.21%
  • Shares traded1.55k
  • 1 Year change-39.74%
  • Beta0.7384
Data delayed at least 15 minutes, as of May 29 2024 08:57 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

STENOCARE A/S is a Denmark-based company, which is engaged in the production of medical cannabis products to patients. The Company’s business model has two divisions: Import and wholesale of finished medical cannabis products for Danish patients, as well as Operate own cultivation- and production facility in Denmark to produce finished cannabis products for Danish and European patients. The Company distributes its products through pharmacies and hospitals. Stenocare's head office is located in Randers, Denmark.

  • Revenue in DKK (TTM)4.10m
  • Net income in DKK-16.81m
  • Incorporated2017
  • Employees9.00
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Bioextrax AB publ1.06m-14.40m67.29m----5.65--63.60-0.8034-0.80340.05880.53150.0686--4.96---93.29-86.39-102.02-110.843.62---1,360.93-2,119.90----0.00--420.5124.40-15.21--56.86--
PCI Biotech Holding ASA1.96m-13.29m68.84m7.00--2.70--35.20-0.5443-0.54430.08011.050.0556--0.6848427,142.80-37.78-36.44-41.97-40.14-----679.43-1,055.43----0.0081---37.05-20.7863.13------
Odi Pharma AB (publ)531.88k-2.58m71.22m----53.82--133.90-0.2608-0.26080.05380.13380.10841.226.98---52.58---95.24---53.07---484.96--1.32-14.100.00---55.44--4.67------
Isofol Medical AB (publ)0.00-20.25m72.75m4.00--0.991-----0.1964-0.19640.000.69930.00----0.00-20.49-66.73-24.10-88.27-------1,023.62----0.00---94.37--76.80------
New Nordic Healthbrands AB349.53m-6.61m72.88m70.00--1.07--0.2085-1.64-1.6486.8116.862.161.844.967,367,219.00-4.095.36-9.1610.5565.3267.30-1.892.380.8584-4.440.282147.969.516.28-119.41--28.36--
Toleranzia AB0.00-4.09m79.41m7.00--0.80-----0.0405-0.04050.000.7750.00----0.00-4.50-7.45-4.65-7.78------------0.00------11.79--63.90--
StenoCare A/S4.10m-16.81m86.59m9.00--3.86--21.10-1.13-1.130.26741.220.1285--2.94---52.62-28.16-70.34-35.47-----409.55-371.061.04-5.560.2362---16.30---7.77------
Enorama Pharma AB882.59k-28.99m87.97m5.00--6.35--99.67-1.16-1.160.03530.38580.03271.481.38271,600.00-107.36-73.56-147.57-104.85-287.2643.36-3,285.20-557.420.8487-16.950.0218---80.17-23.71-6.15------
Lipum AB (publ)0.00-24.16m88.92m5.00--13.65-----4.38-4.380.000.47260.00----0.00-159.35-127.85-206.31-184.50-------293,228.70----0.2781------2.38------
Bactiquant A/S12.30m-13.10m89.29m----6.20--7.26-0.6358-0.63580.59710.61330.50553.672.83---53.83-41.26-62.59-47.16-6.1412.89-106.51-71.775.43-8.540.0431---0.689--7.62------
Circa Group AS12.28m-47.10m96.00m17.00--0.4272--7.82-0.6611-0.66110.16982.810.04035.460.91391,104,133.00-15.46---19.96--75.64---383.72--0.7097--0.00--41.73---0.0491------
Xintela AB50.69k-35.15m96.55m----33.92--1,904.56-0.1524-0.15240.00020.00770.0036--0.0088---252.09-181.06-1,065.04-391.61100.00---69,343.59-235,894.00---50.470.00-----45.5418.32---61.47--
Annexin Pharmaceuticals AB (publ)0.00-30.16m99.63m4.00--16.99-----0.1765-0.17650.000.01710.00----0.00-256.08-125.42-351.79-151.33------------0.00-------8.17------
Vo2 Cap Holding AB (publ)222.80m2.09m101.15m103.0047.970.70383.050.4540.06070.06076.504.130.7493--7.033,328,282.000.7023-0.25640.9347-0.383934.6223.360.9373-0.2409--1.180.1564---26.0985.65-57.92---17.96--
PMD Device Solutions AB18.60m-23.51m102.30m1.00------5.50-16.69-16.696.34-4.790.9465--57.42---119.63------58.18---126.39--0.0505-3.00----------------
Vivesto AB0.00-83.67m103.51m14.00--0.8052-----0.2414-0.24140.000.36760.00----0.00-44.66---48.73--------------0.00---100.00--64.80------
Data as of May 29 2024. Currency figures normalised to Stenocare A/S's reporting currency: Danish Krone DKK
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.